Elsevier

The Surgeon

Volume 7, Issue 2, April 2009, Pages 114-119
The Surgeon

Current concepts in gynaecomastia

https://doi.org/10.1016/S1479-666X(09)80026-7Get rights and content

Gynaecomastia is a common breast condition. Each case merits a careful and complete history, with thorough examination and investigations being required in selected patients with progressive disease or suspected sinister pathology. Treatment is usually indicated for any underlying cause, associated symptoms and the gynaecomastia itself. Treatment may be either medical or surgical but must be individualised. Medical treatment may be especially advocated in the symptomatic group. The indications for surgery include failure of medical treatment, intolerable side-effects of necessary drugs, malignancy, small lesions which cause significant distress and patients with large and ptotic gynaecomastia. A careful programme of counselling, pre-operatively in particular, may help to minimise litigation.

References (59)

  • MJ Williams

    Gynaecomastia. Its incidence, recognition and host characterization in 447 autopsy cases

    Am J Med

    (1963)
  • RC Wray et al.

    Correction of extreme gynaecomastia

    Br J Plast Surg

    (1974)
  • MA Hall-Craggs et al.

    Minimally invasive therapy for the treatment of breast tumours

    Eur J Radiol

    (2002)
  • P Persichetti et al.

    Gynaecomastia and the complete circumareolar approach in the surgical management of skin redundancy

    Plast Reconstr Surg

    (2001)
  • FQ Nuttall

    Gynaecomastia as a physical finding in normal men

    J Clin Endocrinol Metal

    (1979)
  • HE Carlson

    Gynaecomastia

    N Engl J Med

    (1980)
  • M Nydick et al.

    Gynaecomastia in adolescent boys

    JAMA

    (1961)
  • SH LaFranchi et al.

    Pubertal gynaecomastia and transient elevation of serum oestradiol level

    Am J Dis Child

    (1975)
  • DM Large et al.

    Twenty-four hour profiles of serum prolactin during male puberty with and without gynaecomastia

    Clin Endocrinol (Oxf)

    (1980)
  • KM Pirke et al.

    Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol

    Acta Endocrinol (Copenh).

    (1975)
  • GD Braunstein

    Gynaecomastia

    N Engl J Med

    (1993)
  • BE Simon et al.

    Classification and surgical correction of gynaecomastia

    Plast Reconstr Surg

    (1973)
  • DL Hemsell et al.

    Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy

    J Clin Invest

    (1977)
  • GD Berkovitz et al.

    Familial gynaecomastia with increased extraglandular aromatization of plasma carbon19-steroids

    J Clin Invest

    (1985)
  • P Coen et al.

    An aromatase-producing sex-cord tumour resulting in prepubertal gynaecomastia

    N Engl J Med

    (1991)
  • F Bidlingmaier et al.

    Plasma testosterone and estrogens in pubertal gynaecomastia

    Z Kinderheilkd

    (1973)
  • LI Rose et al.

    Pathophysiology of spironolactone-induced gynaeco-mastia

    Ann Intern Med

    (1977)
  • DS Grosso et al.

    Ketoconazole inhibition of testicular secretion oftestosterone and displacement of steroid hormones from serum transport proteins

    Antimicrob Agents Chemother

    (1983)
  • SM Rifka et al.

    Interaction of digitalis and spironolactone with human sex steroid receptors

    J Clin Endocrinol Metab

    (1978)
  • Cited by (20)

    • Diagnostic Pathology: Pediatric Neoplasms

      2018, Diagnostic Pathology: Pediatric Neoplasms
    • Gynaecomastia surgery in the Netherlands: What, why, who, where...

      2014, Journal of Plastic, Reconstructive and Aesthetic Surgery
    • Approach to the patient with gynecomastia

      2011, Journal of Clinical Endocrinology and Metabolism
      Citation Excerpt :

      Several parts of the evaluation process remain controversial. Some authors have recommended performing mammography and/or breast ultrasound in all cases (50–52); in agreement with others (24, 53–58), my own practice has been to use these imaging tools only when there are physical findings that raise a suspicion of breast cancer or a BRCA-2 mutation is suspected or known to be present. Although the sensitivity and specificity of mammography are both greater than 90% in the diagnosis of male breast cancer, the much higher prevalence of gynecomastia compared with breast cancer leads to a positive predictive value of only 55% (59).

    • Gynecomastia

      2014, Benign Disease of the Breast: Diagnosis and Treatment
    View all citing articles on Scopus
    View full text